Enigma Diagnostics

The UK-based firm is selling technology underlying its point-of-care molecular diagnostics platform, the Enigma MiniLab.

NEW YORK (GenomeWeb) — Researchers at Johns Hopkins University have performed the first validation of the Cepheid Xpert Flu assay in a population of emergency room patients with acute undifferentiated respiratory illness.